expand allshow everything
Statistics at a glance
Just look
| Once again | New fall rate - SEER 8 | Rate neuer Fälle - SEER 12 | Mortality rate — SEER 8 incidence-based mortality | 5-year relative survival - SEER 8 | ||||
|---|---|---|---|---|---|---|---|---|
| observed | patterned trend | observed | patterned trend | observed | patterned trend | observed | patterned trend | |
| 1975 | 3.13 | 3.13 | - | - | - | - | 36,05% | 41,29% |
| 1976 | 2,96 | 2,95 | - | - | - | - | 41,13% | 41,40% |
| 1977 | 2.74 | 2,78 | - | - | - | - | 38,80% | 41,52% |
| 1978 | 2.91 | 2,96 | - | - | - | - | 39,21% | 41,63% |
| 1979 | 3.22 | 3.14 | - | - | - | - | 38,35% | 41,74% |
| 1980 | 3.28 | 3.35 | - | - | - | - | 40,64% | 41,85% |
| 1981 | 3,55 | 3.56 | - | - | - | - | 42,23% | 41,96% |
| one thousand nine hundred eighty two | 3,85 | 3,79 | - | - | - | - | 38,95% | 42,07% |
| 1983 | 3,82 | 4.03 | - | - | - | - | 46,07% | 42,19% |
| 1984 | 4.43 | 4.28 | - | - | - | - | 41,71% | 42,30% |
| 1985 | 4.52 | 4,56 | - | - | - | - | 46,95% | 42,41% |
| 1986 | 5.07 | 4,85 | - | - | - | - | 40,53% | 42,52% |
| 1987 | 5.25 | 5.16 | - | - | - | - | 45,58% | 42,63% |
| 1988 | 5.42 | 5.48 | - | - | - | - | 43,84% | 42,74% |
| 1989 | 5.69 | 5.83 | - | - | - | - | 39,88% | 42,85% |
| 1990 | 6.25 | 6.21 | - | - | - | - | 40,60% | 42,96% |
| 1991 | 6.23 | 6.20 | - | - | - | - | 43,39% | 43,08% |
| 1992 | 6.13 | 6.19 | 6.07 | 6.21 | 2,80 | 2,98 | 40,77% | 43,19% |
| 1993 | 6.30 am | 6.18 | 6.15 | 6.18 | 2.73 | 2.91 | 42,44% | 43,30% |
| 1994 | 6.16 | 6.17 | 6.04 | 6.15 | 2.69 | 2.84 | 44,62% | 43,41% |
| 1995 | 6.42 | 6.16 | 6.22 | 6.13 | 2.82 | 2,78 | 42,34% | 43,52% |
| 1996 | 5,95 | 6.15 | 5.84 | 6.10 | 2.76 | 2.71 | 46,24% | 46,18% |
| 1997 | 6.10 | 6.14 | 6.15 | 6.07 | 2,78 | 2,65 | 48,60% | 48,80% |
| 1998 | 6.08 | 6.14 | 5,95 | 6.04 | 2,94 | 2.59 | 51,22% | 51,36% |
| 1999 | 5.91 | 6.13 | 5.88 | 6.01 | 2.41 | 2.53 | 52,69% | 53,86% |
| 2000 | 5.82 | 6.12 | 5.76 | 5,99 | 2.63 | 2.47 | 55,30% | 56,29% |
| 2001 | 6.32 | 6.11 | 6.16 | 5,96 | 2.68 | 2.42 | 58,11% | 58,65% |
| 2002 | 5,95 | 6.10 | 5.92 | 5,93 | 2.32 | 2.36 | 64,63% | 60,92% |
| 2003 | 6.23 | 6.09 | 6.07 | 5,90 | 2.30 | 2.31 | 61,65% | 61,43% |
| 2004 | 6.23 | 6.08 | 6.19 | 5.88 | 2.29 | 2.25 | 61,60% | 61,94% |
| 2005 | 5,98 | 6.03 | 5,94 | 5,85 | 1,99 | 2.20 | 65,29% | 62,44% |
| 2006 | 5.86 | 5,97 | 5.88 | 5.82 | 2.15 | 2.15 | 62,64% | 62,94% |
| 2007 | 6.02 | 5.91 | 5,97 | 5,80 | 2.08 | 2.10 | 62,94% | 63,43% |
| 2008 | 5,95 | 5.86 | 5.84 | 5.77 | 1,91 | 2.05 | 63,41% | 63,91% |
| 2009 | 5.86 | 5,80 | 5.88 | 5.74 | 1,86 | 2.01 | 66,23% | 64,40% |
| 2010 | 5.83 | 5,75 | 5.77 | 5.72 | 1,93 | 1,96 | 65,95% | 64,87% |
| 2011 | 5.54 | 5,70 | 5.49 | 5.69 | 1,90 | 1,92 | 65,98% | 65,35% |
| 2012 | 5.76 | 5.64 | 5.74 | 5.66 | 1,89 | 1,87 | 67,73% | 65,82% |
| 2013 | 5.41 | 5.59 | 5.58 | 5.64 | 1,71 | 1,83 | 67,85% | 66,28% |
| 2014 | 5,55 | 5.54 | 5.57 | 5.61 | 1,82 | 1,79 | 66,06% | 66,74% |
| 2015 | 5.51 | 5.49 | 5.58 | 5.58 | 1,87 | 1,75 | - | 67,20% |
| 2016 | 5.40 | 5.43 | 5.56 | 5.56 | 1,75 | 1,71 | - | 67,65% |
| 2017 | 5.40 | 5.38 | 5.44 | 5.53 | 1.63 | 1,67 | - | 68,09% |
| 2018 | 5.51 | 5.33 | 5.52 | 5.51 | 1,67 | 1.63 | - | 68,53% |
| 2019 | 5.13 | 5.28 | 5.30 | 5.48 | 1,59 | 1,59 | - | 68,97% |
New cases are from SEER 12. Deaths are from SEER 8 Incidence-Based Mortality.
All races, both sexes. The prices are adjusted according to age.
The modeled trend lines were calculated using the underlying pricesJoinpoint-Trendanalysesoftware.
New cases are also referred to as incident cases in other publications. New case rates are also called incidence rates.
5 years
relative survival
64,6%2012-2018
Rate of new cases and deaths per 100,000:The rate of new cases of diffuse large B-cell lymphoma was 5.6 per 100,000 men and women per year. The mortality rate was 1.8 per 100,000 males and females per year. These rates are age-adjusted and based on cases and deaths from 2015-2019.
Further information
- Mortality statistics for diffuse large B-cell lymphoma are based onSEER mortality based on incidence.
Survival Statistics
How many people survive 5 years or more after being diagnosed with diffuse large B-cell lymphoma?
Relative survival is an estimate of the percentage of patients who are expected to survive the effects of cancer. It eliminates the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to accurately predict what will happen to an individual patient. No two patients are exactly alike, and treatment and response to treatment can vary widely.
5 years
relative survival
64,6%
Based on SEER 17 data from 2012-2018. The gray numbers represent those who died from diffuse large B-cell lymphoma. The green numbers represent those who survived 5 years or more.
Relative 5-year survival by sex, age and race
percent
| both genders | 64.570123113 |
|---|---|
| male | 64.266166032 |
| Women | 64.954099603 |
| <55 | 79.422545075 |
| 55–64 | 70.617646389 |
| 65+ | 54.770318493 |
| Branco | 65.092552343 |
| Negro | 60.663914768 |
| Others | 63.459658031 |
SEER 17 2012–2018
Further information
- More on survival statistics
- Additional non-Hodgkin lymphoma survival statistics from SEER*Explorer
stage survival
The cancer stage at the time of diagnosis, which refers to the extent of the cancer in the body, determines treatment options and has a strong impact on survival time. The earlier diffuse large B-cell lymphoma is detected, the better a person's chance of survival five years after diagnosis. In diffuse large B-cell lymphoma, 20.5% are diagnosed as stage I. The 5-year relative survival rate for stage I diffuse large B-cell lymphoma is 79.5%.
Percentage of cases and relative 5-year survival by stage at diagnosis: diffuse large B-cell lymphoma
| scenario | percent of cases | 5 years relative survival |
|---|---|---|
| Phase I Limited to a single region | 20% | 79,5% |
| Stadium II Inclusion of several regions | 20% | 74,6% |
| Stove 3 Spread to both sides of the membrane | 18% | 65,5% |
| Stadium IV Diffuse or widespread effects | 36% | 54,7% |
| A foreign not staged | 6% | 54,9% |
Percentage of cases by stage
Stufe I (20%)
Limited to a single region- Stadium II (20 %)
Inclusion of several regions - Stadium III (18 %)
Spread to both sides of the membrane - Stadium IV (36 %)
Diffuse or widespread effects - Unknown (6%)
not staged
Stufe I (20%)
Stadium II (20 %)
Stadium III (18 %)
Stadium IV (36 %)
Unknown (6%)5 years relative survival
SEER 17 2012-2018, all races, both sexes from Ann Arbor Stage.
Statistics by stage include only cases coded as lymphoma or lymphoma-CLL/SLL2018 EOD Program Definitions.
Further information
- Learn more about staging diffuse large B-cell lymphoma
- Additional non-Hodgkin lymphoma statistics by stage in SEER*Explorer
new cases
who has this cancer
The rate of new cases of diffuse large B-cell lymphoma was 5.6 per 100,000 men and women per year based on age-adjusted cases from 2015 to 2019.
Rate of new cases per 100,000 people by race/ethnicity and sex: diffuse large B-cell lymphoma (DLBCL)
male
| all races | 6.7 |
|---|---|
| non-Hispanic white | 6.9 |
| non-Hispanic black | 5,0 |
| Non-Hispanic Asian/Pacific Islander | 6.3 |
| Non-Hispanic Native American/Alaskan | 5.1 |
| Spanish | 7.3 |
Women
| all races | 4.6 |
|---|---|
| non-Hispanic white | 4.5 |
| non-Hispanic black | 3.5 |
| Non-Hispanic Asian/Pacific Islander | 4.5 |
| Non-Hispanic Native American/Alaskan | 4.5 |
| Spanish | 5.4 |
- all races
- non-Hispanic white
- non-Hispanic black
- non-Hispanic Asian/
pacific island - Non-Hispanic/
Alaska Natives - Spanish
SEER 22 2015–2019, altersbereinigt
Percentage of new cases by age group: diffuse large B-cell lymphoma
| age group | Percentage of new cases |
|---|---|
| <20 | 1,2% |
| 20–34 | 5,3% |
| 35–44 | 6,2% |
| 45–54 | 11,5% |
| 55–64 | 21,2% |
| 65–74 | 26,2% |
| 75–84 | 20,0% |
| >84 | 8,4% |
Diffuse large B-cell lymphoma is most commonly diagnosed in people between the ages of 65 and 74.
middle Ages
no diagnosis
66
SEER 22 2015–2019, all breeds, both sexes
evaluate trends
Changes over time
Tracking new cases, deaths, and survival rates over time (trends) can help scientists understand where progress is being made and where more research is needed to address challenges like improving detection or finding better treatments.
Using statistical models for analysis, age-adjusted rates of new cases of diffuse large B-cell lymphoma decreased by an average of 0.9% each year between 2010 and 2019. Age-adjusted death rates remained stable between 2010 and 2019. Relative one-year survival trends are shown below.
New cases, deaths and 5-year relative survival
New cases are from SEER 8. Deaths are from SEER 8 Incidence-Based Mortality.
All races, both sexes. The prices are adjusted according to age.
The modeled trend lines were calculated using the underlying pricesJoinpoint-Trendanalysesoftware.
SEER 8 percent 5-year relative survival from 1975 to 2014, all races, both sexes.
The modeled trend lines were calculated using the underlying pricesJoinpoint Survival Modeling Software.
Interactive statistics with SEER*Explorer
With SEER*Explorer you can...
- Create custom charts and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. Provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites by stage and histology.
Explore additional non-Hodgkin lymphoma statistics
More about this cancer
Non-Hodgkin's Lymphoma
Figure: Lymph nodes above and below the diaphragm
Illustration: This image shows the lymph nodes above and below the diaphragm. It also shows the lymphatic vessels, tonsils, thymus gland and spleen.
Lymphoma is a cancer that begins in the cells of the lymphatic system. The lymphatic system is part of the immune system, which helps the body fight infection and disease. Because lymphoid tissue is found throughout the body, lymphoma can start almost anywhere.
The two main types of lymphoma are Hodgkin's lymphoma and non-Hodgkin's lymphoma (NHL). These can occur in both children and adults.
There are many different types of NHL, made up of different types of white blood cells (B cells, T cells, NK cells). Most types of NHL are made up of B cells. NHL can be sluggish (slow growing) or aggressive (fast growing). The most common types of NHL in adults are diffuse large B-cell lymphoma, which is usually aggressive, and follicular lymphoma, which is usually indolent.
Further information
Learn more about non-Hodgkin lymphoma
More information
Here are some resources to learn more about non-Hodgkin lymphoma.
- Learn more about risk factors for non-Hodgkin's lymphoma
- Learn more about non-Hodgkin lymphoma symptoms and diagnosis
- Learn more about treatment options for non-Hodgkin lymphoma
- More about clinical trials
- More about cancer prevention
references
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found thereSEER*Batedor.
suggested quote
All material in this report is in the public domain and may be reproduced or copied without permission; however, a reference to the source is desired.
SEER cancer statistics: Diffuse large B-cell lymphoma, National Cancer Institute. Bethesda, MDhttps://seer.cancer.gov/statfacts/html/dlbcl.html
These statistics focus on vital statistics based on the US population. Because these statistics are based on large groups of people, they cannot be used to accurately predict what will happen to an individual patient. To see custom stats, browseSEER*Batedor. To view statistics for a specific condition, go toState Cancer Profiles.
The statistics presented in this Statistical Data are based on the latest available data, most of which can be found atSEER*Batedor. In some cases, different annual periods can be used.
Estimates of new cases and deaths for 2022 are projections from the American Cancer Society (ACS) based on previously published data.
Cancer is a complex subject. There is a wide range of information. These statistics do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision-making, although links are provided to information in many of these areas.
FAQs
What are the statistics for diffuse large B cell lymphoma? ›
The estimated rate for diffuse large B-cell lymphomas is approximately 4.68 cases per 100,000 person-years. It is estimated that approximately 80,470 new cases of NHL will be diagnosed and 20,250 patients will die from NHL in 2022, despite currently available treatment.
Is diffuse large B cell lymphoma cancerous? ›Diffuse large B cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma (NHL). NHL is a cancer of the lymphatic system. It develops when the body makes abnormal B lymphocytes.
What is the survival rate for diffuse large B cell lymphoma? ›...
Diffuse large B-cell lymphoma.
| SEER Stage | 5-Year Relative Survival Rate |
|---|---|
| Regional | 73% |
| Distant | 57% |
| All SEER stages combined | 64% |
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in the United States and worldwide, accounting for about 22 percent of newly diagnosed cases of B-cell NHL in the United States. More than 18,000 people are diagnosed with DLBCL each year.
Can you survive stage 4 diffuse large B-cell? ›Diffuse large b cell lymphoma stage 4 survival rate for 5 years by stage according to SEER: Localized: 73% Regional: 73% Distant: 57%
How fast does DLBCL spread? ›They usually grow quite quickly, over just a few weeks. Sometimes, DLBCL can develop in lymph nodes deep inside your body where they can't be felt from the outside. The swollen nodes can form large lumps – known as 'bulky disease'. DLBCL can also develop outside lymph nodes, called 'extranodal' disease.
Is diffuse large B-cell lymphoma terminal? ›It can be fatal if left untreated. All lymphomas, including DLBCL, affect the organs of your lymphatic system. Your lymphatic system is what allows your body to fight infections.
Can you survive stage 4 B-cell lymphoma? ›Stage 4 non-Hodgkin's diffuse large B-cell lymphoma has a five-year relative survival rate of 57%15. Stage 4 non-Hodgkin's follicular lymphoma has a five-year relative survival rate of 86%15. Stage 4 Hodgkin's lymphoma has a five-year relative survival rate of 82%16.
What are 3 facts about lymphoma? ›Age increases the risk of most cancers, including lymphoma. Sex is a risk factor; males are more likely than females to be diagnosed. Race increases risk; Caucasians are more likely to develop lymphoma. Previous cancer treatment with chemotherapy and radiation can increase risk.
What are the survival statistics for lymphoma? ›The overall 5-year survival rate for people with NHL in the United States is 73%. For stage I NHL, the 5-year survival rate is more than 84%. For stage II the 5-year survival rate is 77%, and for stage III it is more than 71%. For stage IV NHL, the 5-year survival rate is almost 64%.
What causes death from lymphoma? ›
People with NHL most often die from infections, bleeding or organ failure resulting from metastases. A serious infection or sudden bleeding can quickly lead to death, even if someone doesn't appear very ill.
What percent of DLBCL patients relapse? ›Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Approximately 30% to 40% of patients will develop relapsed/refractory (R/R) DLBCL, leading to significant morbidity and mortality.
What is the risk factor for diffuse large B-cell lymphoma? ›Infections that weaken the immune system
Infection with human immunodeficiency virus (HIV), also known as the AIDS virus, can weaken the immune system. HIV infection is a risk factor for developing certain types of NHL, such as primary CNS lymphoma, Burkitt lymphoma, and diffuse large B-cell lymphoma.
Despite a general favourable outcome in limited stage diffuse large B-cell lymphoma (DLBCL), relapses occur in about 10 to 20% of patients.